Trial Outcomes & Findings for Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD (NCT NCT00333710)
NCT ID: NCT00333710
Last Updated: 2014-12-15
Results Overview
This is a 62-item measure which assesses knowledge of the hepatitis C Virus. Range is 0 to 62. Higher scores reflect greater hepatitis C knowledge
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
53 participants
Primary outcome timeframe
pre-treatment, post-treatment
Results posted on
2014-12-15
Participant Flow
Participant milestones
| Measure |
Individual Face-to-face Contact
Individual face-to-face contact treatment
Individual psychotherapy: Individual face-to-face contact with educational and goal setting components
|
Individual Telephone Contact
Individual telephone contact treatment
Telehealth Intervention: Individual telephone contact with educational and goal setting components
|
Control Condition/Treatment as Usual
Control condition/treatment as usual
|
|---|---|---|---|
|
Overall Study
STARTED
|
19
|
18
|
16
|
|
Overall Study
COMPLETED
|
8
|
14
|
15
|
|
Overall Study
NOT COMPLETED
|
11
|
4
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluating a Telehealth Treatment for Veterans With Hepatitis C and PTSD
Baseline characteristics by cohort
| Measure |
Individual Face-to-face Contact
n=19 Participants
Individual face-to-face contact treatment
Individual psychotherapy: Individual face-to-face contact with educational and goal setting components
|
Individual Telephone Contact
n=18 Participants
Individual telephone contact treatment
Telehealth Intervention: Individual telephone contact with educational and goal setting components
|
Control Condition/Treatment as Usual
n=16 Participants
Control condition/treatment as usual.
No active treatment
|
Total
n=53 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
54.37 years
STANDARD_DEVIATION 4.89 • n=5 Participants
|
52.28 years
STANDARD_DEVIATION 5.19 • n=7 Participants
|
55 years
STANDARD_DEVIATION 6.80 • n=5 Participants
|
53.85 years
STANDARD_DEVIATION 5.64 • n=4 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
16 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
49 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
19 participants
n=5 Participants
|
18 participants
n=7 Participants
|
16 participants
n=5 Participants
|
53 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: pre-treatment, post-treatmentThis is a 62-item measure which assesses knowledge of the hepatitis C Virus. Range is 0 to 62. Higher scores reflect greater hepatitis C knowledge
Outcome measures
| Measure |
Individual Face-to-face Contact
n=8 Participants
Individual face-to-face contact treatment
Individual psychotherapy: Individual face-to-face contact with educational and goal setting components
|
Individual Telephone Contact
n=14 Participants
Individual telephone contact treatment
Telehealth Intervention: Individual telephone contact with educational and goal setting components
|
Control Condition/Treatment as Usual
n=15 Participants
Control condition/treatment as usual
|
|---|---|---|---|
|
Hepatitis C Virus Knowledge Questionnaire
Pre-Treatment
|
37.88 units on a scale
Standard Deviation 10.78
|
40.50 units on a scale
Standard Deviation 6.19
|
35.80 units on a scale
Standard Deviation 10.05
|
|
Hepatitis C Virus Knowledge Questionnaire
Post-Treatment
|
45.38 units on a scale
Standard Deviation 7.89
|
42.36 units on a scale
Standard Deviation 6.03
|
34.73 units on a scale
Standard Deviation 11.09
|
Adverse Events
Individual Face-to-face Contact
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Individual Telephone Contact
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Control Condition/Treatment as Usual
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place